398 related articles for article (PubMed ID: 31484501)
1. Low dose of IL-2 combined with rapamycin restores and maintains the long-term balance of Th17/Treg cells in refractory SLE patients.
Zhao C; Chu Y; Liang Z; Zhang B; Wang X; Jing X; Hao M; Wang Y; An J; Zhang X; Sun L; Chen J
BMC Immunol; 2019 Sep; 20(1):32. PubMed ID: 31484501
[TBL] [Abstract][Full Text] [Related]
2. Restoring T-helper 17 cell/regulatory T-cell balance and decreasing disease activity by rapamycin and all-trans retinoic acid in patients with systemic lupus erythematosus.
Chu Y; Zhao C; Zhang B; Wang X; Wang Y; An J; Chen J
Lupus; 2019 Oct; 28(12):1397-1406. PubMed ID: 31551029
[TBL] [Abstract][Full Text] [Related]
3. Belimumab restores Treg/Th17 balance in patients with refractory systemic lupus erythematosus.
Prete M; Leone P; Frassanito MA; Desantis V; Marasco C; Cicco S; Dammacco F; Vacca A; Racanelli V
Lupus; 2018 Oct; 27(12):1926-1935. PubMed ID: 30180771
[TBL] [Abstract][Full Text] [Related]
4. Chloroquine Autophagic Inhibition Rebalances Th17/Treg-Mediated Immunity and Ameliorates Systemic Lupus Erythematosus.
An N; Chen Y; Wang C; Yang C; Wu ZH; Xue J; Ye L; Wang S; Liu HF; Pan Q
Cell Physiol Biochem; 2017; 44(1):412-422. PubMed ID: 29141242
[TBL] [Abstract][Full Text] [Related]
5. Imbalance between Th17 and regulatory T-cells in systemic lupus erythematosus.
Kleczynska W; Jakiela B; Plutecka H; Milewski M; Sanak M; Musial J
Folia Histochem Cytobiol; 2011; 49(4):646-53. PubMed ID: 22252759
[TBL] [Abstract][Full Text] [Related]
6. The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus.
Wang D; Huang S; Yuan X; Liang J; Xu R; Yao G; Feng X; Sun L
Cell Mol Immunol; 2017 May; 14(5):423-431. PubMed ID: 26435067
[TBL] [Abstract][Full Text] [Related]
7. Altered Th17/Treg Ratio in Peripheral Blood of Systemic Lupus Erythematosus but Not Primary Antiphospholipid Syndrome.
Álvarez-Rodríguez L; Martínez-Taboada V; Calvo-Alén J; Beares I; Villa I; López-Hoyos M
Front Immunol; 2019; 10():391. PubMed ID: 30894863
[No Abstract] [Full Text] [Related]
8. Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus.
Kato H; Perl A
J Immunol; 2014 May; 192(9):4134-44. PubMed ID: 24683191
[TBL] [Abstract][Full Text] [Related]
9. Peripheral blood Th17/Treg imbalance in patients with low-active systemic lupus erythematosus.
Szmyrka-Kaczmarek M; Kosmaczewska A; Ciszak L; Szteblich A; Wiland P
Postepy Hig Med Dosw (Online); 2014; 68():893-8. PubMed ID: 24988609
[TBL] [Abstract][Full Text] [Related]
10. Resolvin D1 Improves the Treg/Th17 Imbalance in Systemic Lupus Erythematosus Through miR-30e-5p.
Cheng T; Ding S; Liu S; Li X; Tang X; Sun L
Front Immunol; 2021; 12():668760. PubMed ID: 34093566
[TBL] [Abstract][Full Text] [Related]
11. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
[TBL] [Abstract][Full Text] [Related]
12. Vitamin A improve Th17 and Treg regulation in systemic lupus erythematosus.
Handono K; Firdausi SN; Pratama MZ; Endharti AT; Kalim H
Clin Rheumatol; 2016 Mar; 35(3):631-8. PubMed ID: 26852315
[TBL] [Abstract][Full Text] [Related]
13. CD4
Kato R; Sumitomo S; Tsuchida Y; Tsuchiya H; Nakachi S; Sakurai K; Hanata N; Nagafuchi Y; Kubo K; Tateishi S; Kanda H; Okamura T; Yamamoto K; Fujio K
Front Immunol; 2019; 10():1619. PubMed ID: 31354747
[TBL] [Abstract][Full Text] [Related]
14. Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus.
He J; Zhang X; Wei Y; Sun X; Chen Y; Deng J; Jin Y; Gan Y; Hu X; Jia R; Xu C; Hou Z; Leong YA; Zhu L; Feng J; An Y; Jia Y; Li C; Liu X; Ye H; Ren L; Li R; Yao H; Li Y; Chen S; Zhang X; Su Y; Guo J; Shen N; Morand EF; Yu D; Li Z
Nat Med; 2016 Sep; 22(9):991-3. PubMed ID: 27500725
[TBL] [Abstract][Full Text] [Related]
15. Add-on sirolimus for the treatment of mild or moderate systemic lupus erythematosus via T lymphocyte subsets balance.
Ding M; Jin L; Zhao J; Yang L; Cui S; Wang X; He J; Chang F; Shi M; Ma J; Song S; Jin H; Liu A
Lupus Sci Med; 2024 Feb; 11(1):. PubMed ID: 38351097
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppressive therapy influences the accelerated age-dependent T-helper cell differentiation in systemic lupus erythematosus remission patients.
Schaier M; Gottschalk C; Uhlmann L; Speer C; Kälble F; Eckstein V; Müller-Tidow C; Meuer S; Mahnke K; Lorenz HM; Zeier M; Steinborn A
Arthritis Res Ther; 2018 Dec; 20(1):278. PubMed ID: 30563559
[TBL] [Abstract][Full Text] [Related]
17. The Regulatory T Cell in Active Systemic Lupus Erythematosus Patients: A Systemic Review and Meta-Analysis.
Li W; Deng C; Yang H; Wang G
Front Immunol; 2019; 10():159. PubMed ID: 30833946
[No Abstract] [Full Text] [Related]
18. Rapamycin ameliorates CCl4-induced liver fibrosis in mice through reciprocal regulation of the Th17/Treg cell balance.
Gu L; Deng WS; Sun XF; Zhou H; Xu Q
Mol Med Rep; 2016 Aug; 14(2):1153-61. PubMed ID: 27315465
[TBL] [Abstract][Full Text] [Related]
19. [Expression and significance of Th17 and Treg cells in peripheral blood of patients with systemic lupus erythematosus].
Cai XY; Luo M; Lin XJ; Xu YL; Tang C; Ye JH; Li WN; He ZX; Yu N
Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(7):460-3. PubMed ID: 22490966
[TBL] [Abstract][Full Text] [Related]
20. Altered frequency of Th17 and Treg cells in new-onset systemic lupus erythematosus patients.
Chen M; Chen X; Wan Q
Eur J Clin Invest; 2018 Nov; 48(11):e13012. PubMed ID: 30079446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
